Quick Answer
Biodexa Pharmaceuticals Plc reported Gross Profit of $6.67 million for fiscal year 2017.
Biodexa Pharmaceuticals Plc Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2017 | $6.67M | +6.6% |
| 2016 | $6.26M | +379.4% |
| 2015 | $1.30M | — |
- Biodexa Pharmaceuticals Plc showed an increase of +6.6% in Gross Profit compared to the prior fiscal year.
- Over the 2015–2017 period, Biodexa Pharmaceuticals Plc’s gross profit has grown by 411.3% (from $1.30 million to $6.67 million).
- The most recent figure is from Biodexa Pharmaceuticals Plc’s fiscal year 2017 report (Form 20-F), filed with the SEC on April 24, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: